November 21, 2024 position BIL 91.97% FF 2.01% BKNG 2.30% CASH 3.72% The position in BIL is very large. I'm satisfied with the return from BIL because I can sleep…
Asset Structure Analysis CBRE’ s total assets were $22.55 billion as of December 31, 2023, up from $20.5 billion as of December 31, 2022. Goodwill was $5.13 billion as of…
Vale S.A. ‘s total assets were $94.19 billion at December 31, 2023. The size of fixed assets was very huge. The amount of property, plant and equipment was $48.4 billion…
Asset Structure and Solvency Analysis Microsoft’s fiscal 2024 ended on June 30, 2024 and fiscal 2023 ended on June 30, 2023. Microsoft’s total assets reached $512.16 billion as of June…
Introduction Amerisafe, Inc. is a specialty provider of workers’ compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications,…
We wrote 133 articles about stock analysis. Of 133 articles, most stocks is overvalued and very few stocks is undervalued. Today , we look at these 4 undervalued stock performing.…
Bristol-Myers Squibb(BMY)Q1 2024 Introduction Bristol-Myers Squibb Company(BMY) continues to operate in one segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global…
Introduction Eli Lilly and Company (referred to as the company, Lilly, we, or us) was incorporated in 1901 in Indiana to succeed to the drug manufacturing business founded in Indianapolis,…
Description of the Company and Business Segments Johnson & Johnson and its subsidiaries (the Company) have approximately 152,700 employees worldwide engaged in the research and development, manufacture and sale of…
Company Overview(from AbbVie(ABBV)’s 2022 form 10k) AbbVie(ABBV)is a global, diversified research-based biopharmaceutical company positioned for success with a comprehensive product portfolio that has leadership positions across immunology, oncology, aesthetics, neuroscience…
Investment advice We reckon that $168 per share is a good buy point. Introduction Amgen(AMGN)operate in six commercial areas: inflammation, oncology/hematology, bone health, cardiovascular (CV) disease, nephrology and neuroscience. …
Summary We reckon that Novartis AG(NVS)’ stock price was overestimated ,and $73 per share is a good buy point. Introduction Novartis AG(NVS) is a multinational group of company specializing in…
Summary Regeneron Pharmaceuticals has much money and the debt ratio is very lower. The firm’ financial performance fluctuate substantially, which trigger the fluctuation of the stock price. The company value…
Summary Gilead Sciences, inc. is a cash cow. We reckon that $80 billion market value for the company is reasonable . The acquisitions is an expansion model, which is unpredictable.…